Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial.

Plasma Osteopontin Levels and Adverse Cardiovascular Outcomes in the PEACE Trial.

Osteopontin (OPN) is a secreted glycophosphoprotein that has a role in inflammation, immune response and calcification. We hypothesized that plasma OPN levels are associated with adverse cardiovascular outcomes in patients with stable coronary artery disease (CAD) and preserved ejection fraction (EF...

Full description

Bibliographic Details
Main Authors: Ahmed D Abdalrhim, Tariq S Marroush, Erin E Austin, Bernard J Gersh, Nusret Solak, Syed A Rizvi, Kent R Bailey, Iftikhar J Kullo
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2016-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4902195?pdf=render

Internet

http://europepmc.org/articles/PMC4902195?pdf=render

Similar Items